101 related articles for article (PubMed ID: 28748990)
1. [Clinical features of patients with Basedow Graves disease seen at a university hospital].
Lanas A; Díaz P; Eugenin D; González F; Cid P; Cordero F; Araya V; Liberman C; Barberan M; Gac P; Saldías N; Pineda P
Rev Med Chil; 2017 Apr; 145(4):436-440. PubMed ID: 28748990
[TBL] [Abstract][Full Text] [Related]
2. [Epidemiological, clinical, therapeutic and evolutive aspects of Basedow-Graves disease in the Depatment of Internal Medicine at CHU Aristide Le Dantec, Dakar (Senegal)].
Diagne N; Faye A; Ndao AC; Djiba B; Kane BS; Ndongo S; Pouye A
Pan Afr Med J; 2016; 25():6. PubMed ID: 28154699
[TBL] [Abstract][Full Text] [Related]
3. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
[TBL] [Abstract][Full Text] [Related]
4. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.
Bahn Chair RS; Burch HB; Cooper DS; Garber JR; Greenlee MC; Klein I; Laurberg P; McDougall IR; Montori VM; Rivkees SA; Ross DS; Sosa JA; Stan MN; ;
Thyroid; 2011 Jun; 21(6):593-646. PubMed ID: 21510801
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcome of Graves' disease in Thai children.
Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy after definitive treatment for Graves' disease--does treatment choice influence outcome?
Elston MS; Tu'akoi K; Meyer-Rochow GY; Tamatea JA; Conaglen JV
Aust N Z J Obstet Gynaecol; 2014 Aug; 54(4):317-21. PubMed ID: 24576228
[TBL] [Abstract][Full Text] [Related]
7. Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report.
Cunha FM; Rodrigues E; Oliveira J; Saavedra A; Vinhas LS; Carvalho D
J Med Case Rep; 2016 Mar; 10():70. PubMed ID: 27029843
[TBL] [Abstract][Full Text] [Related]
8. [A case of Graves-Basedow disease with orbitopathy and papillary thyroid cancer].
Bałdys-Waligórska A; Gołkowski F; Sokołowski G; Buziak-Bereza M; Skalski M; Hubalewska-Dydejczyk A
Endokrynol Pol; 2008; 59(6):516-20. PubMed ID: 19347817
[TBL] [Abstract][Full Text] [Related]
9. Outcome of very long-term treatment with antithyroid drugs in Graves' hyperthyroidism associated with Graves' orbitopathy.
Elbers L; Mourits M; Wiersinga W
Thyroid; 2011 Mar; 21(3):279-83. PubMed ID: 21190446
[TBL] [Abstract][Full Text] [Related]
10. Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.
Popoveniuc G; Sharma M; Devdhar M; Wexler JA; Carroll NM; Wartofsky L; Burman KD
Thyroid; 2010 Sep; 20(9):1015-8. PubMed ID: 20718680
[TBL] [Abstract][Full Text] [Related]
11. Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.
Woo YJ; Jang SY; Lim TH; Yoon JS
Korean J Ophthalmol; 2015 Aug; 29(4):213-9. PubMed ID: 26240504
[TBL] [Abstract][Full Text] [Related]
12. Thyroid diseases after treatment of Hodgkin's disease.
Hancock SL; Cox RS; McDougall IR
N Engl J Med; 1991 Aug; 325(9):599-605. PubMed ID: 1861693
[TBL] [Abstract][Full Text] [Related]
13. The many causes of subclinical hyperthyroidism.
Charkes ND
Thyroid; 1996 Oct; 6(5):391-6. PubMed ID: 8936661
[TBL] [Abstract][Full Text] [Related]
14. [Current questions of thyroid diseases in childhood].
Ilyés I
Orv Hetil; 2011 Apr; 152(16):617-27. PubMed ID: 21454178
[TBL] [Abstract][Full Text] [Related]
15. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
Khoo DH; Eng PH; Ho SC; Tai ES; Morgenthaler NG; Seah LL; Fong KS; Chee SP; Choo CT; Aw SE
Thyroid; 2000 Dec; 10(12):1093-100. PubMed ID: 11201855
[TBL] [Abstract][Full Text] [Related]
16. Surgical management of Graves disease in childhood and adolescence: an institutional experience.
Sherman J; Thompson GB; Lteif A; Schwenk WF; van Heerden J; Farley DR; Kumar S; Zimmerman D; Churchward M; Grant CS
Surgery; 2006 Dec; 140(6):1056-61; discussion 1061-2. PubMed ID: 17188157
[TBL] [Abstract][Full Text] [Related]
17. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
[TBL] [Abstract][Full Text] [Related]
18. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O
Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819
[TBL] [Abstract][Full Text] [Related]
19. Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease.
Schmidt M; Gorbauch E; Dietlein M; Faust M; Stützer H; Eschner W; Theissen P; Schicha H
Thyroid; 2006 Mar; 16(3):281-8. PubMed ID: 16571091
[TBL] [Abstract][Full Text] [Related]
20. Thyroid volume and severity of Graves' orbitopathy.
Profilo MA; Sisti E; Marcocci C; Vitti P; Pinchera A; Nardi M; Rocchi R; Latrofa F; Menconi F; Altea MA; Leo M; Rago T; Marinò M
Thyroid; 2013 Jan; 23(1):97-102. PubMed ID: 23088654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
